MktsMarkets

Vaxcyte, Inc.
NASDAQ: PCVXKey statistics
PCVX News
Stories mentioning PCVX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 312,779 | 242,060 | 209,933 | 194,179 | 148,134 | 133,614 | 116,936 | 131,507 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 345,850 | 274,283 | 242,380 | 226,219 | 180,793 | 162,169 | 139,924 | 152,981 |
| Operating Income (Loss) | (345,850) | (274,283) | (242,380) | (226,219) | (180,793) | (162,169) | (139,924) | (152,981) |
| Interest Income | 26,610 | 26,451 | 29,259 | 31,073 | 32,935 | 36,458 | 28,057 | 23,813 |
| Interest Expense | ||||||||
| Other Expense | (1,382) | 1,325 | 291.00 | 28,573 | 7,140 | (11,369) | 8,743 | 465.00 |
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (320,622) | (246,507) | (212,830) | (166,573) | (140,718) | (137,080) | (103,124) | (128,703) |
| Earnings Per Share (Basic) | (2.30) | (1.81) | (1.56) | (1.22) | (1.04) | (1.12) | (0.83) | (1.10) |
| Earnings Per Share (Diluted) | (2.30) | (1.81) | (1.56) | (1.22) | (1.04) | (1.12) | (0.83) | (1.10) |
| Weighted Average Shares Outstanding (Basic) | 139,507 | 136,090 | 136,197 | 136,034 | 135,691 | 121,997 | 123,693 | 117,257 |
| Weighted Average Shares Outstanding (Diluted) | 139,507 | 136,090 | 136,197 | 136,034 | 135,691 | 121,997 | 123,693 | 117,257 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PCVX
Vaxcyte, Inc. (NASDAQ: PCVX) is a stock listed on the Nasdaq Stock Market under the ticker symbol PCVX. It last traded at $63.89 (Nov 6, 2026, 4:00 PM ET), up 3.2% on the day. That gives Vaxcyte a market capitalisation of $10.1B.
Over the past 52 weeks PCVX has traded between $40.14 and $90.75.
For the quarter ended Mar 31, 2026 it reported a net loss of $320.6M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$320.6M |
| Dec 31, 2025 | — | -$246.5M |
| Sep 30, 2025 | — | -$212.8M |
| Jun 30, 2025 | — | -$166.6M |
From Vaxcyte’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…